Related Experiment Video
Updated: May 16, 2025
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Primary sarcoma of the prostate: A case series of 6 patients
Ping Yang1, Li Wang2, Yang He3
1Department of Oncology, Shanghai Eighth People's Hospital, Shanghai, China.
Rationale:
Primary prostate sarcomas are highly malignant tumors characterized by their low incidence and poor prognosis. Due to this rarity, we present a limited number of case series.
Patient Concerns:
In this report, we detail the clinical diagnosis, treatment, and prognosis of the last 6 primary prostatic sarcoma cases.
Diagnoses:
The 6 patients, all adults aged between 21 and 51 years, were diagnosed pathologically through needle biopsy or surgical specimens.
Interventions:
All patients underwent chemotherapy.
Outcomes:
At the time of the last follow-up, only 1 patient continued treatment, while the other 5 had succumbed to disease progression. The overall survival time ranged from 3 to 46 months.
Lessons:
Primary prostatic sarcoma presents with an insidious onset and rapid progression, lacking standard treatment options and associated with a very poor prognosis. Early detection and timely surgical intervention may improve the cure rate and extend survival time for affected patients.
